Ken Griffin Organovo Holdings, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.75 - $1.35 $1,950 - $3,510
2,600 Added 16.05%
18,800 $14,000
Q1 2024

May 15, 2024
BUY
$0.9 - $1.17 $14,580 - $18,954
16,200 New
16,200 $16,000
Q2 2023

Aug 14, 2023
SELL
$1.64 - $2.24 $8,364 - $11,424
-5,100 Reduced 39.84%
7,700 $13,000
Q1 2023

May 15, 2023
BUY
$1.44 - $3.2 $18,432 - $40,960
12,800 New
12,800 $28,000

Others Institutions Holding ONVO

# of Institutions
36
Shares Held
2.33M
Call Options Held
18.8K
Put Options Held
0
View Full List

About ORGANOVO HOLDINGS, INC.

ONVO Quotes by TradingView
  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $4.01M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email